(19)
(11) EP 4 185 278 A1

(12)

(43) Date of publication:
31.05.2023 Bulletin 2023/22

(21) Application number: 21845536.8

(22) Date of filing: 20.07.2021
(51) International Patent Classification (IPC): 
A61K 9/70(2006.01)
A61K 31/192(2006.01)
A61K 33/38(2006.01)
A61L 15/44(2006.01)
A61P 17/02(2006.01)
C07C 39/19(2006.01)
C07C 65/19(2006.01)
A61K 31/05(2006.01)
A61K 31/352(2006.01)
A61K 36/185(2006.01)
A61L 29/16(2006.01)
A61P 31/04(2006.01)
C07C 39/23(2006.01)
C07D 311/58(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 31/05; A61K 31/192; A61K 31/352; A61K 33/38; A61K 36/185; A61L 15/44; A61L 29/16; A61P 17/02; A61P 31/04; A61L 2300/406; A61L 2300/104; A61L 29/085; A61L 29/145; A61L 15/60; A61K 9/7007; Y02A 50/30
 
C-Sets:
  1. A61K 31/352, A61K 2300/00;
  2. A61L 29/085, C08L 29/04;
  3. A61K 33/38, A61K 2300/00;
  4. A61K 31/05, A61K 2300/00;
  5. A61K 31/192, A61K 2300/00;

(86) International application number:
PCT/CA2021/051005
(87) International publication number:
WO 2022/016269 (27.01.2022 Gazette 2022/04)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 22.07.2020 US 202063055211 P
10.11.2020 US 202063111972 P

(71) Applicant: The University of British Columbia
Vancouver, British Columbia V6T 1Z3 (CA)

(72) Inventors:
  • JACKSON, John K.
    Vancouver, British Columbia V7W 2H4 (CA)
  • THOMPSON, Charles J.
    Vancouver, British Columbia V6K 1C1 (CA)
  • LAMBERT, Dana M.
    Vancouver, British Columbia V7W 2H7 (CA)
  • DOSANJH, Manisha
    Surrey, British Columbia V3X 1S9 (CA)

(74) Representative: De Clercq & Partners 
Edgard Gevaertdreef 10a
9830 Sint-Martens-Latem
9830 Sint-Martens-Latem (BE)

   


(54) SILVER ENHANCED CANNABINOID ANTIBIOTICS